Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 16 hours ago
As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the grey’
about 16 hours ago
Eversana Intouch, the AI-powered marketing agency arm of Eversana, pulled seasoned advertising...
Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
1 day ago
Explore how targeted protein degradation is reshaping drug discovery, enabling new approaches...
Integrated CDO capabilities reduce early development complexity
1 day ago
Strengthening core CDO values for cell line development
Trump plans to fire FDA chief Marty Makary: report
1 day ago
President Donald Trump has approved a plan to fire FDA Commissioner Marty...
Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
1 day ago
During the weeklong stay by the Supreme Court to temporarily restore online...
Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
1 day ago
With an FDA decision date looming for its Duchenne muscular dystrophy (DMD)...
Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
1 day ago
Gilead raised its previous guidance of $800 million in revenues from the...
Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
1 day ago
Daiichi Sankyo is poised to report significantly lower full-year profit for fiscal...
AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboard
1 day ago
After losing the top spot in March to Johnson & Johnson’s immunology...
Johnson & Johnson launches ‘Generation Fine’ depression project
1 day ago
You’ve heard of Gen Z, but now Johnson & Johnson wants you...
Revisiting Pharma’s tariff reality
1 day ago
Fierce Pharma’s Fraiser Kansteiner catches up with KPMG’s Chris Young to discuss...
Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
1 day ago
Summit's PD-1xVEGF study surprisingly missed its mark at an interim analysis. UCB...